437.85
price up icon0.16%   0.68
after-market Dopo l'orario di chiusura: 437.85
loading

Madrigal Pharmaceuticals Inc Azioni (MDGL) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
55.05%
212.80
137.25 103.32 62.17 14.64
Operating Expenses
20.06%
260.00
216.56 164.08 178.48 177.18
Benefits Costs and Expenses
100.00%
-
210.49 162.74 - -
Costs And Expenses
23.52%
260.00
210.49 194.72 178.48 177.18
Operating Income/Loss
40.48%
-47.20
-79.31 -67.00 -116.30 -162.54
Income/Loss From Continuing Operations Before Tax
390.56%
212.80
-73.24 -59.42 62.17 -151.97
Income/Loss From Continuing Operations After Tax
42.27%
-42.28
-73.24 -59.42 -106.96 -151.97
Net Income/Loss
42.27%
-42.28
-73.24 -59.42 -106.96 -151.97
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.52%
22.21
22.09 0.2204 21.75 21.40
Diluted Average Shares
0.52%
22.21
22.09 0.2204 21.75 21.40
Basic Earnings Per Share
42.77%
-1.90
-3.32 -2.59 -4.92 -7.10
Diluted Earnings Per Share
42.77%
-1.90
-3.32 -2.59 -4.92 -7.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
Capitalizzazione:     |  Volume (24 ore):